Soleno Therapeutics, Inc.
(SLNO - NASDAQ)
52,75 USD
📋 Profilo Aziendale

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

|